Reply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation". [electronic resource]
- Journal of hepatology Apr 2014
- 896-7 p. digital
Publication Type: Letter; Comment
1600-0641
10.1016/j.jhep.2013.11.032 doi
Female Hepatitis C, Chronic--drug therapy Humans Liver Transplantation Male Protease Inhibitors--therapeutic use